Chris Degnan

Chief Financial Officer, Verrica Pharmaceuticals Inc.

Companies

UroGen Pharma Ltd.Chief financial officer Oct 9, 2024 to now¹
Galera Therapeutics, Inc.Chief financial officer Nov 6, 2019 to Mar 14, 2023²
Verrica Pharmaceuticals Inc.Chief financial officer Jun 14, 2018 to Mar 4, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

UroGen Pharma Ltd. URGN2,280 shares⁴$78.0K at $34.19Oct 8, 2025
Galera Therapeutics, Inc.10,000 shares⁵Mar 13, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 8, 2025Sold 2,203 shares at $16.85 of UroGen Pharma Ltd.⁴
Oct 8, 2025Exercised options 4,483 shares of UroGen Pharma Ltd.⁴
Mar 13, 2023Bought 10,000 shares at $1.96 of Galera Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARUroGen Pharma Ltd., Chief financial officer
2
SEC EDGARGalera Therapeutics, Inc., Chief financial officer
3
SEC EDGARVerrica Pharmaceuticals Inc., Chief financial officer
4
SEC EDGARUroGen Pharma Ltd. shares after the filing of Oct 8, 2025
5
SEC EDGARGalera Therapeutics, Inc. shares after the filing of Mar 13, 2023